NCT03581630View on ClinicalTrials.gov

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 29, 2017

Primary Completion Date

July 22, 2018

Study Completion Date

July 22, 2018

Conditions
Breast CancerObesityOverweight
Interventions
DRUG

naltrexone/bupropion

Naltrexone hydrochloride (HCl) 8 mg/Bupropion hydrochloride (HCl) 90 mg extended release (ER) combination tablets, orally, one tablet, in the morning, daily, for 1 week, followed by Naltrexone HCl 8 mg/Bupropion HCl 90 mg ER combination tablets, orally, one tablet in the morning and one in the evening, daily, for 7 weeks.

BEHAVIORAL

Mediterranean Diet

Diet instruction and menu samples from the dietitian on following the Mediterranean Diet.

Trial Locations (1)

Unknown

GangnamSeverance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT03581630 - Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients | Biotech Hunter | Biotech Hunter